This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (January 2022)
Salvatore Novo was graduated with honors in Medicine from the University of Palermo in 1972 and post-graduated in Cardiovascular Diseases & Internal Medicine at the University of Palermo, and also post-graduated in Medical Angiology from University of Catania.[3][4]
Novo previously worked as an Associate Professor of Clinical Pathophysiology in University of Catania and Palermo. Then, he became a full Professor of CV Diseases at the University of Palermo.
Research and career
During his service in the University of Palermo and University Hospital "Paolo Giaccone" of Palermo, he was Director of the chair and post-graduate School of CVD, II level Master of Echocardiography and Vascular Diseases, and teaching of CVD several post-graduate Schools of the School of Medicine and Director of the Division of Clinical Cardiology with Haemodynamics, Electrophysiology and stimulation as well as Rehabilitation.[citation needed]
Honorary Member of the Czech Society of Angiology - Purkinje Academy (2005)
Fellow of the American College of Cardiology (FACC), since 2012.[5]
Honorary member of the Italian Association of Cardio-Oncology (since 2012).
Publications
2016 European Guidelines on cardiovascular disease prevention in clinical practice.[6]
Electrocardiographic abnormalities, preclinical carotid atherosclerosis andcardiovascular risk, in an apparently healthy real-world population: data from the project "No Stroke, No Infarction" of the rotary international - District 2110 "Sicily & Malta".[7]
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.[8]
Moderate alcohol use and health: a consensus document.[9]
Critical limb ischemia: definition and natural history.[10]
Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers.[11]
Classification, epidemiology, risk factors, and natural history of peripheral arterial disease.[12]
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations.[13]
This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles.(August 2021)
